Closure of Trading Window
Awaiting price reaction for this filing.
Sarda Proteins Ltd has informed BSE that the trading window for dealing in its securities will be closed for designated persons and their immediate relatives starting 1st April 2026. The window will remain shut until 48 hours after the company declares its audited financial results for the quarter and year ended 31st March 2026. The board meeting date to consider and approve these results will be communicated separately. The intimation has been made in line with SEBI's Prohibition of Insider Trading Regulations, 2015.
This is a routine regulatory compliance filing and does not directly impact shareholders. It signals that the company's Q4 and full-year FY26 audited results are likely to be announced in the coming weeks, which could be a near-term catalyst for the stock.